DVA Trading Analysis - 10/06/2026 01:29 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge context for DaVita (DVA) suggests the following themes that may be relevant to current trading conditions:

• Kidney-care providers including DVA have faced ongoing Medicare reimbursement policy discussions, creating sector uncertainty.
• DVA has historically been sensitive to labor-cost inflation and staffing pressures in dialysis clinics.
• Potential debt-refinancing activity or credit-rating commentary has been a recurring headline item for the company.
• No specific confirmed earnings date is cited here, but fiscal year end per data is 2025-12-01, implying annual reporting cycles ahead.
• Broader healthcare-services M&A speculation has periodically included DVA as a rumored target, which can drive options interest.

This news context is separated from the data-driven sections below, which rely strictly on the embedded datasets provided.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for DVA:

• Trailing P/E is 14.30 with trailing EPS of 12.46, implying a relatively modest valuation versus broader market multiples.
• Market cap is 11,546,843,000.00 with shares outstanding of 63,800,000.00.
• Dividend yield is 0.00 and no dividend rate is declared (null), indicating a non-income stock currently.
• Beta is 1.23, showing moderate-high sensitivity to market moves.
• 52-week high is 247.49 and 52-week low is 101.00; current price near 178.25 is well below the annual high.
• Institutional ownership is 28.81%, relatively low for a large-cap healthcare name.
• Average volume is 715,000.00 and historical volatility is 31.50%.
• PEG ratio, forward P/E, forward EPS, profit margins, ROE, debt/equity, and free cash flow are all null in the data — fundamental strength beyond earnings and valuation cannot be confirmed.
• Analyst target mean price and recommendation key are null; no consensus context is available.
• Fundamentals (low P/E, positive EPS) appear stable but diverge from the bearish technical picture shown in indicators.

Current Market Position

From the DAILY HISTORY and MINUTE BARS data:

• Latest daily close (2026-10-05) is 178.26; intraday bars show 2026-10-06 13:00 close at 181.35, up from 179.26 at 2026-10-05 09:30.
• Minute bars reveal opening 2026-10-05 at 177.96 and drifting to 178.11 by 09:50, then recovering to 181.35 by 2026-10-06 13:00.
• Daily range on 2026-10-05 was low 177.43 / high 179.66; recent daily weakness from 193.86 (2026-09-16) to 174.67 (2026-09-24).
• 30-day high is 195.75 and low is 171.40; current price sits in lower-middle of that range.

Technical Analysis

• Price (178.26) is below SMA 5 (176.95? actually above), SMA 20 (181.61), and SMA 50 (188.36) — bearish alignment with 5 > price? Correct: SMA5 176.95 < price 178.26, but price < SMA20 < SMA50 = bearish structure.
• RSI at 33.14 indicates weak momentum, nearing oversold but not yet extreme.
• MACD (-3.39) below signal (-2.71) with negative histogram (-0.68) = bearish momentum.
• Bollinger lower band at 171.59; price is inside lower half of bands, no squeeze detected (width ~20.04).
• 30-day range: price at 178.26 is 30.6% above low (171.40) and 8.9% below high (195.75).

True Sentiment Analysis (Delta 40-60 Options)

From the TRUE SENTIMENT OPTIONS data (methodology: Delta 40-60 only):

Call Dollar Volume: 6030.00 (83.4%) Put Dollar Volume: 1200.00 (16.6%) Total: 7230.00

• Sentiment is Bullish with 83.4% call dollar volume vs 16.6% put.
• Only 3 true-sentiment options traded (6 calls / 3 puts), small sample but directional conviction favors calls.
• Options flow suggests near-term upside expectations despite weak technicals.
• Divergence: Technicals bearish (RSI 33.14, MACD negative) while options sentiment bullish — confirmed by spread recommendation "divergence detected".

Key Price Levels (Observational Only)